UNSPSC 85571305: Insertion of endobronchial valve into left lower lobe bronchus, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a surgical intervention or procedure to insertion of endobronchial valve into left lower lobe bronchus, via natural or artificial opening endoscopic. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0BHB8GZ

UNSPSC 85571305 Insertion of endobronchial valve into left lower lobe bronchus, via natural or artificial opening endoscopic (Commodity) does not align with the recent state and local contract opportunities tagged under this code. The code nominally describes a specific clinical procedure—the placement of an endobronchial valve—but the recent solicitations posted under this code span independent medical evaluation services for disability pension determinations, surgical and medical procedure carve-out benefits, occupational health surveillance, emergency and specialty medical care for detained youth, pharmacy benefit management, and temporary health professional staffing. None of these opportunities involve endobronchial valve insertion or related pulmonary interventions. The mismatch between the code's procedure-specific name and the actual scope of work being solicited suggests either systematic miscoding by the posting jurisdictions or use of the code as a catch-all placeholder for diverse health services procurement that does not match the UNSPSC taxonomy's granular commodity structure.

The issuing bodies span multiple state and local government types, including city retirement offices (City of Phoenix), municipalities (City of Long Beach), state transportation departments (Washington State Department of Transportation), county probation systems (Harris County), county health consortiums (Collier County), and regional health systems (County of Santa Clara). Recent opportunities show activity across Arizona, California, Florida, Washington, and Texas, with response dates ranging from September 25, 2026 through October 9, 2026. Given the fundamental disconnect between the code's clinical definition and the actual services being procured, firms should not rely on this code as a filtering signal for endobronchial valve or related pulmonary device procurement opportunities at the state and local level.